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Abstract
We report a mother and daughter with autosomal recessive ataxia with occulomotor apraxia in whom sequence
analysis of senataxin revealed a dignosis of AOA2 (ataxia with occulomotor apraxia type 2) in both individuals. The
apparent dominant inheritance pattern (pseudodominant) was the result of the unusual coincidence of both
mother and daughter being compound heterozygotes for senataxin mutations. Our case exemplifies the challenges
of diagnosis in hereditary ataxias, and the limitations of genetic testing guided solely by patterns of inheritance.
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Background
Ataxia with occulomotor apraxia type 2 (AOA2) is a rare
autosomal recessive cerebellar ataxia caused by muta-
tions in the senataxin gene (SETX) [1]. It is characterised
by a progressive early-onset cerebellar ataxia, sensori-
motor peripheral neuropathy and variably present occu-
lomotor apraxia [2]. Raised alpha-feto-protein (AFP) and
cerebellar atrophy are typical. The diagnosis of hereditary
ataxias is often problematic [3]. Targeted genetic testing is
guided by the phenotype, in which the pattern of inherit-
ance is crucial. We report the unusual case of pseudodo-
minance in a family with autosomal recessive AOA2.
Case presentation
A mother (Ia) and daughter (IIa) with a presumed auto-
somal dominant early-onset cerebellar ataxia were
reviewed in the Sheffield (UK) Ataxia Clinic. The 47 year
old female IIa had a longstanding history of cerebellar
ataxia spanning three decades. She had initially pre-
sented with incoordination and diplopia aged 11. Pro-
gressive deterioration in gait had resulted in the use of a
wheelchair by adulthood. Age 47 she retained the ability
to transiently weight bear, with a severely ataxic gait on
assisted walking. On examination she had signs of cere-
bellar dysfunction including limb and truncal ataxia,
dysarthria, intention tremor, dysdiadokinesis and dys-
metric finger pointing bilaterally. Horizontal and vertical
gaze-evoked nystagmus and dysmetric saccades were
present, without occulomotor apraxia. Symmetrical distal
weakness and wasting were marked, with generalised are-
flexia. Plantar responses were normal. Sensory deficits
included impaired vibration and pinprick sensation in
the lower limbs and left forearm. Telangiectasia was not
evident. She did not suffer from frequent infections and
there was no history of cancer in her or her family. MRI
demonstrated cerebellar and mild supratentorial atrophy.
Neurophysiology showed a length dependent axonal sen-
sorimotor peripheral neuropathy. AFP was elevated on
repeated testing ranging from 63–72 KU/l (normal range
0-15KU/L). Immunoglobulins and vitamin levels were
normal. The mother of the index patient (Ia) shared a
similar phenotype of progressive early-onset cerebellar
ataxia (in her teens), severe length dependent axonal poly-
neuropathy, elevated AFP (149KU/L), and cerebellar atro-
phy. She presented to the respiratory physicians at the age
of 65 because of respiratory difficulties. She was wheel-
chair bound with severe distal muscle wasting. Investiga-
tions suggested that her respiratory problems were
secondary to her severe neuropathy. Although disabled for
many years she was never investigated for her neurological
problems prior to her respiratory problems. Mother and
daughter had no contact with the biological father of IIa.
There were no other siblings and thus no further family
history was available.
Genetic analysis
Both patients underwent genetic testing for Friedreich’s
ataxia and common Spinocerebellar ataxias (SCA1, 2, 3,
6, 7) which were negative. In view of the unusual com-
bination of an apparently dominantly-inherited cerebel-
lar ataxia with a raised AFP, DNA was sent for further
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genetic analysis. Sequencing of the entire coding region
of SETX identified two pathogenic mutations in patient
IIa confirming the diagnosis of AOA2, including: c.5274 +
4_5274 + 7del with a predicted effect on splicing and
c.6686_6687insCAAC; p.Met2229Ilefs*43 which may re-
sult in loss of expression through nonsense mediated
decay or a truncated protein. c.5274 + 4 5274 + 7del was
inherited from the mother (Ia) who was also a compound
heterozygote with a second likely loss of function mutation
(c.7121_7122delTG; p. Val2374Glyfs*20). These SETX mu-
tations are not present in the LOVD UCL Neurogenetics
SETX database, although both the c.6686_6687insCAAC
and c.7121_7122delTG SETX mutations have been identi-
fied in previous cases of AOA2 in the UK. It is unclear
whether c.6686_6687insCAAC represents a de novo muta-
tion or was inherited paternally. Unfortunately genetic ma-
terial was unavailable from the estranged father.
Conclusions
The diagnosis of hereditary ataxias is often challenging
[3]. There is substantial overlap in the phenotypes of
these genetically distinct disorders with significant vari-
ability in their presentation. Given the apparent auto-
somal dominant pattern of inheritance the family were
tested for the common autosomal dominant ataxias
(SCA1, 2, 3, 6, 7). The unusual combination of an ele-
vated AFP in an apparent ‘autosomal-dominant’ ataxia
with axonal neuropathy led to the consideration of an
atypically inherited AOA2. Raised AFP is not seen in
other ataxias associated with severe axonal neuropathy
(eg SCA4, 18, 25, AOA1 and SCAN) [4]. Furthermore,
the occurrence of cerebellar atrophy and severe neur-
opathy in the context of normal immune function and
immunoglobulins, absent telangiectasia and onset in the
second decade would be more suggestive of AOA2 than
Ataxia Telangiectasia. Occulomotor apraxia may be ab-
sent in approximately 50% of patients [2]. Misleading
patterns of inheritance in AOA2 have been previously
reported [5,6]. In this case, the false categorisation of
AOA2 as an autosomal dominant ataxia was explained
by the unusual coincidence of a mother (Ia) with AOA2
who was a compound heterozygote for 2 SETX muta-
tions having a daughter (IIa) with AOA2 who was also a
compound heterozygote for mutations in SETX.
The absence of paternal genetic material means we are
unable to clarify the source of patient IIa’s additional SETX
mutation (de novo or paternally inherited). Pseudodomi-
nance is often observed in the context of consanguinity, al-
though no such history was elicited in this family.
The correlation between genotype and phenotype in
AOA2 remains unclear. It has been proposed that muta-
tions in the SETX helicase domain, particularly missense,
may be associated with a mildly attenuated phenotype
characterised by slower progression compared with other
SETX sites [2]. However, the clinical phenotype of AOA2
remains relatively homogenous in most series. Interest-
ingly, although fertility has not been directly studied,
hypogondatrophic hypogonadism has been reported in 2
female patients with AOA2 in a previous cohort [2]. The
present case report confirms the reproductive fitness of at
least some individuals with AOA2.
Considering the continually expanding number of gen-
etic mutations associated with hereditary ataxias, mo-
lecular genetic diagnosis is often never achieved or done
so after a lengthy time period. Algorithms for genetic
testing sometimes rely on panels targeted at specific pat-
terns of inheritance, particularly for autosomal dominant
families [3]. The present case highlights the limitations
of such an approach, especially when applied without
considering additional clinical information. Next gener-
ation sequencing (NGS) is already offering a more com-
prehensive and rapid molecular genetic evaluation of
potentially inherited diseases. Interestingly, such ataxia
panel tests include both autosomal dominant and reces-
sive ataxias [7].
Consent
The patients have given consent for the report to be
published.
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